Linaklotid (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Linaklotid" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

2^nd place

8^th place

4^th place

11^th place

5^th place

22^nd place

222^nd place

312^th place

low place

low place

610^th place

1,534^th place

1tandfonline.com

507^th place

831^st place

68^th place

37^th place

cenblog.org

Oh, See Arr (2011. augusztus 17.). „Macrocycle Milestone for Ironwood Pharma”. The Haystack. (Hozzáférés: 2017. február 11.)

doi.org

dx.doi.org

Góngora-Benítez, Miriam, Marta (2011. július 9.). „Optimized Fmoc solid-phase synthesis of the cysteine-rich peptide linaclotide” (angol nyelven). Biopolymers 96 (1), 69–80. o. DOI:10.1002/bip.21480.
Ahsan, Md. Kaimul, Marco M. (2017. június 1.). „Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine” (angol nyelven). Physiological Reports 5 (11), e13299. o. DOI:10.14814/phy2.13299. PMID 28592587.
Castro, Joel, Patrick A. (2013. december 1.). „Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate” (angol nyelven). Gastroenterology 145 (6), 1334–1346.e11. o. DOI:10.1053/j.gastro.2013.08.017.
Quigley, E. M. M., W. D. (2013. január 1.). „Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints”. Alimentary Pharmacology & Therapeutics 37 (1), 49–61. o. DOI:10.1111/apt.12123. ISSN 1365-2036. PMID 23116208.
Lee, Noel (2011. május 1.). „The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide” (angol nyelven). Expert Opinion on Drug Metabolism & Toxicology 7 (5), 651–659. o. DOI:10.1517/17425255.2011.572875. ISSN 1742-5255.

elsevier.com

linkinghub.elsevier.com

Castro, Joel, Patrick A. (2013. december 1.). „Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate” (angol nyelven). Gastroenterology 145 (6), 1334–1346.e11. o. DOI:10.1053/j.gastro.2013.08.017.

europa.eu

ema.europa.eu

EMA Kísérőirat. (Hozzáférés: 2019. május 17.)

nih.gov

ncbi.nlm.nih.gov

Thomas, Rachel Hutchins (2013. március 1.). „Linaclotide (Linzess) for Irritable Bowel syndrome With Constipation and For Chronic Idiopathic Constipation”. P & T: A Peer-Reviewed Journal for Formulary Management 38 (3), 154–160. o. ISSN 1052-1372. PMID 23641133.
Ahsan, Md. Kaimul, Marco M. (2017. június 1.). „Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine” (angol nyelven). Physiological Reports 5 (11), e13299. o. DOI:10.14814/phy2.13299. PMID 28592587.
Quigley, E. M. M., W. D. (2013. január 1.). „Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints”. Alimentary Pharmacology & Therapeutics 37 (1), 49–61. o. DOI:10.1111/apt.12123. ISSN 1365-2036. PMID 23116208.

tandfonline.com

Lee, Noel (2011. május 1.). „The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide” (angol nyelven). Expert Opinion on Drug Metabolism & Toxicology 7 (5), 651–659. o. DOI:10.1517/17425255.2011.572875. ISSN 1742-5255.

wiley.com

doi.wiley.com

Góngora-Benítez, Miriam, Marta (2011. július 9.). „Optimized Fmoc solid-phase synthesis of the cysteine-rich peptide linaclotide” (angol nyelven). Biopolymers 96 (1), 69–80. o. DOI:10.1002/bip.21480.
Ahsan, Md. Kaimul, Marco M. (2017. június 1.). „Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine” (angol nyelven). Physiological Reports 5 (11), e13299. o. DOI:10.14814/phy2.13299. PMID 28592587.

worldcat.org

Thomas, Rachel Hutchins (2013. március 1.). „Linaclotide (Linzess) for Irritable Bowel syndrome With Constipation and For Chronic Idiopathic Constipation”. P & T: A Peer-Reviewed Journal for Formulary Management 38 (3), 154–160. o. ISSN 1052-1372. PMID 23641133.
Quigley, E. M. M., W. D. (2013. január 1.). „Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints”. Alimentary Pharmacology & Therapeutics 37 (1), 49–61. o. DOI:10.1111/apt.12123. ISSN 1365-2036. PMID 23116208.
Lee, Noel (2011. május 1.). „The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide” (angol nyelven). Expert Opinion on Drug Metabolism & Toxicology 7 (5), 651–659. o. DOI:10.1517/17425255.2011.572875. ISSN 1742-5255.